CMS’s May 15 final rule removes the federal standardized-plan requirement for 2027. That could make ACA shopping less straightforward, especially for people who need to weigh premiums against deductibles and other out-of-pocket costs.
Most tooth pain is not an antibiotic problem. But fever, facial or jaw swelling, swallowing trouble, voice change, trismus, or breathing symptoms should not wait.
Probably not automatically. The FDA’s June 10, 2026 label change for alli adds a warning about rare kidney stones and kidney injury, but the practical question is whether you have risk factors or symptoms that mean you should pause and get medical advice.
CDC’s confirmed U.S. measles count topped 2,000 in 2026. If you get an exposure notice from a school, child care center, or workplace, the most useful next steps are to check written vaccine records quickly, follow local instructions, and call ahead if symptoms start.
Starting July 1, 2026, Medicare’s temporary GLP-1 Bridge may help some beneficiaries with obesity and prior cardiovascular disease get certain GLP-1 drugs for a flat $50 a month. But if Wegovy is prescribed for its FDA-approved cardiovascular-risk-reduction use, CMS says that claim generally belongs in regular Part D instead of the Bridge.
Federal officials are investigating a June 13, 2026 recall of Nara Organics infant formula after three confirmed or suspected infant botulism illnesses. Here is what parents should do now, which symptoms need emergency care, and what remains uncertain.
Usually not to the child. The new federal Medicaid work rule applies to certain adults, not children or CHIP enrollees. But some parents may still have to comply, depending on their Medicaid category and their state’s rollout.
An American Cancer Society guideline update keeps colorectal cancer screening starting at age 45 for average-risk adults and adds a blood-based option for people who decline or do not complete preferred screening tests.
Parents and caregivers should stop using recalled Nara Organics infant formula right away, watch exposed babies for symptoms of infant botulism for one month, and seek emergency care promptly if signs such as poor feeding, trouble swallowing, floppy muscles, or breathing problems appear.
The FDA’s June 12 clearance expands an over-the-counter glucose monitor to children ages 2 and older who do not use insulin. It may make glucose tracking easier for some families, but it still has important limits on low-sugar warnings, insulin use, dialysis, and insurance coverage.
New trial results have put multi-cancer early detection blood tests back in the spotlight. For adults without symptoms, the evidence is still not strong enough to treat these tests like routine cancer screening.
The first U.S. multisociety CKM guideline says waist size, blood pressure, blood sugar, blood fats, and kidney function should be looked at together—especially if you already have belly weight, prediabetes, or high blood pressure.
No. CMS’s new Medicaid work requirement applies to certain adults, not children on Medicaid or CHIP. But parents and caregivers may still see new paperwork, notices, and eligibility checks that can affect the household.
A new study on FDA-authorized AI-enabled medical devices suggests a simple takeaway: ask whether the tool is FDA-authorized, whether a clinician reviews the result, and how you would learn about a recall or safety alert.
CDC and FDA say to stop using recalled Nara Organics infant formula, watch for infant botulism symptoms for one month after the last use, and get urgent care if a baby seems weak, floppy, or has trouble feeding or swallowing.
CDC says people with a family member who has type 1 diabetes should be offered screening, starting at age 2. With newer FDA-approved uses for Tzield, a positive result can now lead to more specific follow-up discussions, though screening still has important limits.
Yes, some average-risk people ages 30 to 65 can now collect their own HPV screening sample, but the option is limited, follow-up still matters, and symptoms still need in-person care.
Usually, yes. A parent’s Medicaid work-rule problem should not automatically end a child’s Medicaid or CHIP coverage. But renewals, paperwork mistakes, and Medicaid-to-CHIP transitions can still interrupt coverage if families miss notices or deadlines.
Not automatically, but FDA’s April 30, 2026 action was a proposal about one compounding pathway, not a same-day nationwide ban on every refill. Here’s what changed, what may still be possible, and what patients should ask before their next prescription is filled.
A new federal Medicaid rule says certain adults will have to show 80 hours a month of work, school, community service, or other qualifying activity to keep coverage, generally starting January 1, 2027. But the rule has many exemptions, and some of the biggest risks may come from paperwork, verification, and state-by-state implementation details that are still developing.
NOAA expects a quieter Atlantic season, but that does not remove personal risk. Here is how families can protect insulin, refrigerated medicines, and electric medical devices before a storm or outage.
The FDA added a kidney injury and kidney stone warning to alli on June 10, 2026. Here’s what changed, who should be careful, and why the pill is meant to support—not replace—healthy habits.
End of content
End of content
